West Pharmaceutical Services (WST) Current Taxes (2009 - 2026)

West Pharmaceutical Services (WST) has reported Current Taxes for 18 consecutive years, with $64.7 million the latest figure, recorded in Q2 2026.

• Quarterly Current Taxes rose 127.02% year-over-year to $64.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $64.7 million (up 127.02% YoY) and the FY2025 annual result came in at $28.1 million, down 10.79% from the prior year.
• Current Taxes fell to $64.7 million in Q2 2026 per WST's latest filing, from $78.9 million in the prior quarter.
• Over the last five years, Current Taxes for WST reached as high as $78.9 million in Q1 2026 and fell as low as $15.0 million in Q3 2023.
• A 5-year average of $33.0 million and a median of $29.2 million in 2022 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes tumbled 71.53% — and 2026, when it jumped 253.81%.
• Year by year, Current Taxes stood at $24.8 million in 2022, then sank by 33.06% to $16.6 million in 2023, then jumped by 89.76% to $31.5 million in 2024, then decreased by 10.79% to $28.1 million in 2025, then surged by 130.25% to $64.7 million in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $64.7 million, $78.9 million, and $28.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.